search
Back to results

Communication During Hospitalization About Resuscitation Trial (CHART)

Primary Purpose

Severe Life-limiting COPD, Severe Life-limiting Heart Failure, Severe Life-limiting Cirrhosis

Status
Active
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Informed Assent Discussion
Usual Care with Attention Control
Sponsored by
University of Vermont
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Severe Life-limiting COPD

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. >65 years old
  2. English speaking
  3. Must have one or more of the following:

    1. Chronic life-limiting illness with median survival <2 years defined as: 1) metastatic cancer or inoperable lung cancer; 2) COPD requiring oxygen; 3) New York Heart Association Class III or IV heart failure, 4) Child's Class C cirrhosis or MELD score of >20, 5) End-stage renal disease (must be on dialysis and ≥ 75 years old), 6) Advanced pulmonary fibrosis/interstitial lung disease, 7) Advanced pulmonary hypertension
    2. Severe functional impairment defined as dependence with >4 activities of daily living (ADLs) on Katz Index of Independence in ADLs.

Exclusion Criteria:

  1. Has already definitively chosen DNR status
  2. Unable to provide informed consent
  3. Refused consent
  4. Currently listed on a transplant list (awaiting transplant)
  5. Inappropriate for study enrollment per clinician
  6. Known to have a left ventricular assist device (LVAD)
  7. Research team unavailable
  8. Patient discharged from hospital prior to enrollment

Sites / Locations

  • University of North Carolina
  • Medical University of South Carolina
  • University of Vermont
  • University of Washington

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Intervention

Usual Care with Attention Control

Arm Description

Participants (n= approximately 100 plus family members) who are randomized to the intervention arm of the study will participate in a discussion about CPR with a study doctor.

Participants (n= approximately 100 plus family members) who are randomized to the usual care arm will receive a friendly visit in the hospital from research personnel to ask if they have any questions or concerns. Follow up assessments and time windows will be explained. Importance of their participation in the study will be emphasized.

Outcomes

Primary Outcome Measures

Quality of Communication Questionnaire (QOCQ), slightly modified to focus on communication about cardiopulmonary resuscitation
Patient-Assessed Quality of Communication about CPR

Secondary Outcome Measures

Quality of Communication Questionnaire (QOCQ), slightly modified to focus on communication about cardiopulmonary resuscitation
Family-Assessed Quality of Communication about CPR
5-question communication domain of the CANHELP Questionnaire, slightly modified to focus on communication about cardiopulmonary resuscitation
Patient-Assessed Satisfaction with Communication about CPR
5-question communication domain of the CANHELP Questionnaire, slightly modified to focus on communication about cardiopulmonary resuscitation
Family-Assessed Satisfaction with Communication about CPR
Hospital Anxiety and Depression Survey (HADS)
Patient Depressive and Anxiety Symptoms
Hospital Anxiety and Depression Survey (HADS)
Family Depressive and Anxiety Symptoms
Do-Not-Resuscitate Orders (yes/no)
Time to Do-Not-Resuscitate Orders
Admission to the intensive care unit (ICU) 9yes/no)
ICU length of stay (days)
Tracheostomy placement (yes/no)
Gastrostomy tube placement (yes/no)
Receipt of mechanical ventilation (yes/no)
Receipt of renal replacement therapy (yes/no)
Receipt of cardiopulmonary resuscitation (yes/no)
Cost of health care after initial hospitalization
Repeat hospital admissions, ICU admissions, nursing home says, hospice care stays, and use of home health care will be assessed, and if they occurred, duration will be recorded. A standardized value (costs, not charges) will be applied to these measures to determine overall cost.
Mortality (dead or alive)

Full Information

First Posted
November 28, 2016
Last Updated
May 11, 2023
Sponsor
University of Vermont
Collaborators
University of Washington, Medical University of South Carolina, University of North Carolina, Chapel Hill
search

1. Study Identification

Unique Protocol Identification Number
NCT02984124
Brief Title
Communication During Hospitalization About Resuscitation Trial
Acronym
CHART
Official Title
Communication During Hospitalization About Resuscitation Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
December 2016 (undefined)
Primary Completion Date
February 2023 (Actual)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Vermont
Collaborators
University of Washington, Medical University of South Carolina, University of North Carolina, Chapel Hill

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This multicenter RCT of 200 hospitalized patients and their family members evaluates an "informed assent" approach to discussing cardiopulmonary resuscitation, compared to usual care, in older seriously ill hospitalized patients with severe life-limiting illness or severe functional impairment.
Detailed Description
Increasing evidence suggests that high quality palliative care in older patients improves quality of care, patient and family satisfaction, and costs of care. However, while some specific palliative care interventions have been investigated, exactly how we should provide this care remains unclear. One important component of high quality provider-patient communication is discussing cardiopulmonary resuscitation (CPR) within the context of the patient's values and goals of care. Unfortunately, these conversations are often rushed, focused only on the procedure rather than the patient's goals and values, and CPR is often offered as if a choice on a menu. Elderly hospitalized patients are unlikely to have made decisions about CPR prior to hospitalization, and these discussions often leave patients and families feeling burdened, stressed, and concerned. Outcomes after in-hospital CPR in chronically ill older patients continue to be very poor, despite decades of efforts toward improvement. The investigators aim to change the paradigm of CPR discussions with older adults unlikely to benefit from CPR. This study is a randomized controlled trial comparing an innovative "informed assent" approach to discussing CPR versus usual care with attention control for older hospitalized adults with life-limiting illness or severe functional impairment, enrolling patients and family members at three different study sites. Informed assent includes: 1) eliciting values and goals, 2) explaining CPR in the context of illness, and 3) a caring statement that the patient should not receive CPR if values include avoiding burdensome therapies unlikely to provide benefit. Thus, the provider can elicit values, convey information, and state an assessment, while allowing the patient or family to disagree. The investigators hypothesize that informed assent will improve quality of and satisfaction with communication about CPR; reduce the burden of potentially harmful CPR discussions, including reduced patient and family symptoms of depression and anxiety; and reduce intensity of care and health care utilization. The intervention builds on prior work investigating CPR outcomes in older adults and performing pilot studies of the informed assent intervention in both inpatients and outpatients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Severe Life-limiting COPD, Severe Life-limiting Heart Failure, Severe Life-limiting Cirrhosis, Severe Life-limiting Malignancy, Severe Functional Impairment, End Stage Renal Disease

7. Study Design

Primary Purpose
Other
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
182 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
Participants (n= approximately 100 plus family members) who are randomized to the intervention arm of the study will participate in a discussion about CPR with a study doctor.
Arm Title
Usual Care with Attention Control
Arm Type
Placebo Comparator
Arm Description
Participants (n= approximately 100 plus family members) who are randomized to the usual care arm will receive a friendly visit in the hospital from research personnel to ask if they have any questions or concerns. Follow up assessments and time windows will be explained. Importance of their participation in the study will be emphasized.
Intervention Type
Behavioral
Intervention Name(s)
Informed Assent Discussion
Intervention Description
Participants randomized to the intervention arm will participate in a discussion about CPR with a study doctor that follows these steps: Patient's values and preferences for therapies and outcomes elicited from patient and family; overall therapeutic goals formulated Description of CPR and dying process provided Personalized explanation provided about probable lack of achieving any reasonable therapeutic goal with CPR (i.e. why s/he is a poor candidate for CPR due to underlying illness) Patient and family informed that due to severe underlying illness and high likelihood that CPR will be burdensome/harmful and will not provide benefit, CPR will not be offered unless they disagree (except in rare circumstance where overall therapeutic goals from step 1 are to preserve life regardless of quality of that life) Assessment of patient's and family's understanding of issues discussed; patients may actively disagree and request CPR be performed, but CPR not explicitly offered
Intervention Type
Behavioral
Intervention Name(s)
Usual Care with Attention Control
Intervention Description
Participants who are randomized to the usual care arm will receive a friendly visit in the hospital from research personnel to ask if they have any questions or concerns. Follow up assessments and time windows will be explained. Importance of their participation in the study will be emphasized.
Primary Outcome Measure Information:
Title
Quality of Communication Questionnaire (QOCQ), slightly modified to focus on communication about cardiopulmonary resuscitation
Description
Patient-Assessed Quality of Communication about CPR
Time Frame
Study day 5 +/- 1 or hospital discharge, whichever is earlier
Secondary Outcome Measure Information:
Title
Quality of Communication Questionnaire (QOCQ), slightly modified to focus on communication about cardiopulmonary resuscitation
Description
Family-Assessed Quality of Communication about CPR
Time Frame
Study day 5 +/- 1 or hospital discharge, whichever is earlier
Title
5-question communication domain of the CANHELP Questionnaire, slightly modified to focus on communication about cardiopulmonary resuscitation
Description
Patient-Assessed Satisfaction with Communication about CPR
Time Frame
Study day 5 +/- 1 or hospital discharge, whichever is earlier
Title
5-question communication domain of the CANHELP Questionnaire, slightly modified to focus on communication about cardiopulmonary resuscitation
Description
Family-Assessed Satisfaction with Communication about CPR
Time Frame
Study day 5 +/- 1 or hospital discharge, whichever is earlier
Title
Hospital Anxiety and Depression Survey (HADS)
Description
Patient Depressive and Anxiety Symptoms
Time Frame
Study day 5 +/- 1 or hospital discharge (whichever is earlier), 3 months, and 6 months
Title
Hospital Anxiety and Depression Survey (HADS)
Description
Family Depressive and Anxiety Symptoms
Time Frame
Study day 5 +/- 1 or hospital discharge (whichever is earlier), 3 months, and 6 months
Title
Do-Not-Resuscitate Orders (yes/no)
Time Frame
Study day 5 +/- 1 or hospital discharge (whichever is earlier), 3 months, and 6 months
Title
Time to Do-Not-Resuscitate Orders
Time Frame
To 6 months post-randomization
Title
Admission to the intensive care unit (ICU) 9yes/no)
Time Frame
Measured at the time hospital discharge, which will likely occur at an average of 6 days after admission, but will be assessed for up to 6 months.
Title
ICU length of stay (days)
Time Frame
Measured at the time hospital discharge, which will likely occur at an average of 6 days after admission, but will be assessed for up to 6 months.
Title
Tracheostomy placement (yes/no)
Time Frame
Measured at the time hospital discharge, which will likely occur at an average of 6 days after admission, but will be assessed for up to 6 months.
Title
Gastrostomy tube placement (yes/no)
Time Frame
Measured at the time hospital discharge, which will likely occur at an average of 6 days after admission, but will be assessed for up to 6 months.
Title
Receipt of mechanical ventilation (yes/no)
Time Frame
Measured at the time hospital discharge, which will likely occur at an average of 6 days after admission, but will be assessed for up to 6 months.
Title
Receipt of renal replacement therapy (yes/no)
Time Frame
Measured at the time hospital discharge, which will likely occur at an average of 6 days after admission, but will be assessed for up to 6 months.
Title
Receipt of cardiopulmonary resuscitation (yes/no)
Time Frame
Measured at the time hospital discharge, which will likely occur at an average of 6 days after admission, but will be assessed for up to 6 months.
Title
Cost of health care after initial hospitalization
Description
Repeat hospital admissions, ICU admissions, nursing home says, hospice care stays, and use of home health care will be assessed, and if they occurred, duration will be recorded. A standardized value (costs, not charges) will be applied to these measures to determine overall cost.
Time Frame
3 months and 6 months post-randomization
Title
Mortality (dead or alive)
Time Frame
To 6 months post-randomization

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: >65 years old English speaking Must have one or more of the following: Chronic life-limiting illness with median survival <2 years defined as: 1) metastatic cancer or inoperable lung cancer; 2) COPD requiring oxygen; 3) New York Heart Association Class III or IV heart failure, 4) Child's Class C cirrhosis or MELD score of >20, 5) End-stage renal disease (must be on dialysis and ≥ 75 years old), 6) Advanced pulmonary fibrosis/interstitial lung disease, 7) Advanced pulmonary hypertension Severe functional impairment defined as dependence with >4 activities of daily living (ADLs) on Katz Index of Independence in ADLs. Exclusion Criteria: Has already definitively chosen DNR status Unable to provide informed consent Refused consent Currently listed on a transplant list (awaiting transplant) Inappropriate for study enrollment per clinician Known to have a left ventricular assist device (LVAD) Research team unavailable Patient discharged from hospital prior to enrollment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Renee Stapleton, MD PhD
Organizational Affiliation
University of Vermont
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of North Carolina
City
Chapel Hill
State/Province
North Carolina
ZIP/Postal Code
27599
Country
United States
Facility Name
Medical University of South Carolina
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29425
Country
United States
Facility Name
University of Vermont
City
Burlington
State/Province
Vermont
ZIP/Postal Code
05405
Country
United States
Facility Name
University of Washington
City
Seattle
State/Province
Washington
ZIP/Postal Code
98104
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
This study includes quantitative data that the investigators plan to share with other researchers with interests in the quality of care provided to older hospitalized seriously ill patients and their families. De-identified questionnaire data, medical record data, and administrative data will be made available in the form of datasets with no personally identifying characteristics retained, to protect the identity of the respondents.

Learn more about this trial

Communication During Hospitalization About Resuscitation Trial

We'll reach out to this number within 24 hrs